Epidemiology of drug-induced severe skin reactions

Bastuji-Garin, 1996, Drugs associated with bullous pemphigoid, Arch Dermatol, 132, 272, 10.1001/archderm.1996.03890270044006

Roujeau, 1990, Toxic epidermal necrolysis (Lyell's syndrome):Incidence and drug etiology in France, 1981–1985, Arch Dermatol, 126, 37, 10.1001/archderm.1990.01670250043005

Schōpf, 1991, Toxic epidermal necrolysis and Stevens-Johnson syndrome: An epidemiologic study from West Germany, Arch Dermatol, 127, 839, 10.1001/archderm.1991.01680050083008

Hebra von, 1866, Erythema exsudativum multiforme, 54

Stevens, 1922, A new eruptive fever associated with stomatitis and ophthalmia: Report of two cases in children, Am J Dis Child, 24, 526, 10.1001/archpedi.1922.04120120077005

Assier, 1995, Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes, Arch Dermatol, 131, 539, 10.1001/archderm.1995.01690170041005

Bystryn, 1996, Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders, Arch Dermatol, 132, 711, 10.1001/archderm.1996.03890300141023

Lyell, 1956, Toxic epidermal necrolysis: An eruption resembling scalding of the skin, Br J Dermatol, 68, 355, 10.1111/j.1365-2133.1956.tb12766.x

Melish, 1970, The staphylococcal scalded skin syndrome: Development of an experimental model, N Engl J Med, 282, 1114, 10.1056/NEJM197005142822002

Ruiz-Maldonado, 1985, Acute disseminated epidermal necrosis types 1, 2 and 3: Study of sixty cases, J Am Acad Dermatol, 13, 623, 10.1016/S0190-9622(85)70207-1

Lyell, 1990, Requiem for toxic epidermal necrolysis, Br J Dermatol, 122, 837, 10.1111/j.1365-2133.1990.tb06275.x

Bastuji-Garin, 1993, Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme, Arch Dermatol, 129, 92, 10.1001/archderm.1993.01680220104023

Rzany, 1996, Histopathological and epidemiological characteristics of patients with erythema exsudativum multiforme majus (EEMM), Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), Br J Dermatol, 135, 6, 10.1111/j.1365-2133.1996.tb03598.x

Côté, 1995, Clinicopathologic correlation in erythema multiforme and Stevens-Johnson syndrome, Arch Dermatol, 131, 1268, 10.1001/archderm.1995.01690230046008

Roujeau, 1994, Severe adverse cutaneous reactions to drugs, N Engl J Med, 331, 1272, 10.1056/NEJM199411103311906

Mockenhaupt, 1994, Serious cutaneous adverse reactions: Differences in demography and past history of drug intake between Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) and generalized bullous fixed drug eruption (GBFDE), J Invest Dermatol, 102, 619

Villada, 1992, Immunopathology of toxic epidermal necrolysis: Keratinocytes, HLA-DR expression, Langerhans cells, and mononuclear cells: An immunopathologic study of five cases, Arch Dermatol, 128, 50, 10.1001/archderm.1992.01680110060006

Correia, 1993, Cutaneous T-cell recruitment in toxic epidermal necrolysis: Further evidence of CD8+ lymphocyte involvement, Arch Dermatol, 129, 466, 10.1001/archderm.1993.01680250078010

Paquet, 1994, Macrophages and tumor necrosis factor α in toxic epidermal necrolysis, Arch Dermatol, 130, 605, 10.1001/archderm.1994.01690050073012

Haake, 1993, Cell death by apoptosis and epidermal biology, J Invest Dermatol, 101, 107, 10.1111/1523-1747.ep12363594

Paul, 1996, Apoptosis as a mechanism of keratinocyte death in toxic epdermalnecrolysis, Br J Dermatol, 134, 710, 10.1111/j.1365-2133.1996.tb06976.x

Foedinger, 1995, Autoantibodies to desmoplakin I and II in patients with erythema multiforme, J Exp Med, 181, 169, 10.1084/jem.181.1.169

Dietrich, 1995, Low N-acetylating capacity in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis, Exp Dermatol, 4, 313, 10.1111/j.1600-0625.1995.tb00211.x

Roujeau, 1987, Genetic susceptibility to toxic epidermal necrolysis, Arch Dermatol, 123, 1171, 10.1001/archderm.1987.01660330082014

Revuz, 1987, Toxic epidermal necrolysis: Clinical findings and prognosis factors in 87 patients, Arch Dermatol, 123, 1160, 10.1001/archderm.1987.01660330071012

Kaupinnen, 1985, Fixed eruptions: Causative drugs and challenge tests, Br J Dermatol, 112, 575, 10.1111/j.1365-2133.1985.tb15266.x

Chan, 1990, The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: A population-based study with particular reference to reactions caused by drugs among outpatients, Arch Dermatol, 126, 43, 10.1001/archderm.1990.01670250049006

Naldi, 1990, Incidence of toxic epidermal necrolysis in Italy, Arch Dermatol, 126, 1103, 10.1001/archderm.1990.01670320127028

Strom, 1991, A population-based study of Stevens-Johnson syndrome: Incidence and antecedent drug exposures, Arch Dermatol, 127, 831, 10.1001/archderm.1991.01680050075007

Rzany, 1996, Epidemiology of erythema exsudativum multiforme majus (EEMM), Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in Germany (1990–1992): Structure and results of a population-based registry, J Clin Epidemiol, 49, 769, 10.1016/0895-4356(96)00035-2

Mockenhaupt, 1995, Drug attributability in HIV-infected patients with Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), Pharmacoepidemiology and Drug Safety, 4, 54

Schöpf, 1994, 89

Kelly, 1995, An international collaborative case-control study of severe cutaneous adverse reactions (SCAR). Design and methods, J Clin Epidemiol, 48, 1099, 10.1016/0895-4356(95)00004-N

Roujeau, 1995, Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis, N Engl J Med, 333, 1600, 10.1056/NEJM199512143332404

Stern, 1995, Epidemiology of adverse cutaneous reactions to drugs, Dermatoepidemiology, 13, 68